Nothing Special   »   [go: up one dir, main page]

Cathie et al., 1949 - Google Patents

The laboratory diagnosis of toxoplasmosis

Cathie et al., 1949

View PDF
Document ID
6232931436978320702
Author
Cathie I
Dudgeon J
Publication year
Publication venue
Journal of Clinical Pathology

External Links

Snippet

A case of congenital toxoplasmosis has recently been seen in this hospital The patient, a girl aged 5 years, presented with hydrocephalus, bilateral pes cavus, and blindness. The eyes showed exten-sive retinochoroiditis thought to be characteristic of toxoplasmosis …
Continue reading at www.ncbi.nlm.nih.gov (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56916—Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/571—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses for venereal disease, e.g. syphilis, gonorrhoea
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/5695—Mycobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens

Similar Documents

Publication Publication Date Title
Brown et al. Febrile illness in Malaysia—an analysis of 1,629 hospitalized patients
Couch et al. Infection with artificially propagated Eaton agent (Mycoplasma pneumoniae): implications for development of attenuated vaccine for cold agglutinin-positive pneumonia
Weller et al. The etiology of epidemic pleurodynia: a study of two viruses isolated from a typical outbreak
Pereira et al. EB virus antibody at different ages
Echeverria et al. Role of heat-labile toxigenic Escherichia coli and reovirus-like agent in diarrhoea in Boston children
Corbel et al. Differentiation of the serological response to Yersinia enterocolitica and Brucella abortus in cattle
Phillips et al. Persistence of virus in infants with congenital rubella and in normal infants with a history of maternal rubella
D'Alessio et al. Failure of inactivated influenza vaccine to protect an aged population
Jones et al. Toxoplasmic lymphadenitis
Henle et al. Mumps Meningo-Encephalitis. Isolation in Chick Embryos of Virus from Spinal Fluid of a Patient.
Hayward Serological studies with herpes simplex virus
Contreras et al. Identification of Coxsackie viruses by immunological methods and their classification into 16 antigenically distinct types
Cathie et al. The laboratory diagnosis of toxoplasmosis
Phillips et al. Isolation of rubella virus: An epidemic characterized by rash and arthritis
Haynes et al. Echovirus 9 meningoencephalitis in infants and children
Neal et al. Comparison of clinical observations on patients infected with Entamoeba histolytica, with serological titres of their sera and virulence of their amoebae to rats
Hoyle et al. Serological Diagnosis of Epidemic Influenza
Balfour Jr et al. A study of erythema infectiosum: Recovery of rubella virus and echovirus-12
Pearson et al. A study of influenza in Boston during the winter of 1940–1941
HENDERSON et al. EPIDEMIC TYPHUS FEVER: NEUTRALIZATION OF THE TOXIC SUBSTANCE ¹
Andrews et al. An epidemic of respiratory infection due to Mycoplasma pneumoniae in a civilian population
Downie et al. Smallpox and related virus infections in man
FUKUMI et al. Studies on the adenovirus as an etiological agent of pharyngoconjunctival fever
Katsube et al. STUDIES ON TOXOPLASMOSIS I. ISOLATION OF TOXOPLASMA FROM MUSCLES OF HUMANS, DOGS, AND CATS
Mitchell et al. The haemagglutination test for toxoplasma antibodies